WPS Stock Overview
Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
West Pharmaceutical Services, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$281.20 |
| 52 Week High | US$380.10 |
| 52 Week Low | US$253.80 |
| Beta | 1.01 |
| 11 Month Change | 4.65% |
| 3 Month Change | 1.66% |
| 1 Year Change | -8.07% |
| 33 Year Change | -24.41% |
| 5 Year Change | 111.43% |
| Change since IPO | 1,766.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| WPS | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -7.3% | -0.6% | -1.8% |
| 1Y | -8.1% | 15.3% | 13.2% |
Return vs Industry: WPS underperformed the German Life Sciences industry which returned 18.6% over the past year.
Return vs Market: WPS underperformed the German Market which returned 16.1% over the past year.
Price Volatility
| WPS volatility | |
|---|---|
| WPS Average Weekly Movement | 6.1% |
| Life Sciences Industry Average Movement | 6.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: WPS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: WPS's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1923 | 10,600 | Eric Green | www.westpharma.com |
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.
West Pharmaceutical Services, Inc. Fundamentals Summary
| WPS fundamental statistics | |
|---|---|
| Market cap | €20.58b |
| Earnings (TTM) | €461.03m |
| Revenue (TTM) | €2.65b |
45.9x
P/E Ratio8.0x
P/S RatioIs WPS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WPS income statement (TTM) | |
|---|---|
| Revenue | US$2.88b |
| Cost of Revenue | US$1.87b |
| Gross Profit | US$1.00b |
| Other Expenses | US$503.40m |
| Earnings | US$499.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.90 |
| Gross Margin | 34.87% |
| Net Profit Margin | 17.37% |
| Debt/Equity Ratio | 7.4% |
How did WPS perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield12%
Payout RatioDoes WPS pay a reliable dividends?
See WPS dividend history and benchmarks| West Pharmaceutical Services dividend dates | |
|---|---|
| Ex Dividend Date | Nov 13 2024 |
| Dividend Pay Date | Nov 20 2024 |
| Days until Ex dividend | 11 days |
| Days until Dividend pay date | 18 days |
Does WPS pay a reliable dividends?
See WPS dividend history and benchmarks